THBS2 and neoplasm: Thrombospondin 1 and 2 (TSP-1, TSP-2), along with pigment epithelium-derived factor (PEDF), promote tumor-associated lymphangiogenesis, and blocking these targets obviously reduces tumor growth and LN infiltration in intrahepatic CCA [140].